Eli Lilly and Co (LLY)
726.35
-19.60
(-2.63%)
USD |
NYSE |
Apr 19, 16:00
724.62
-1.73
(-0.24%)
After-Hours: 19:00
Eli Lilly Price: 726.35 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 749.42 | 752.20 | 743.77 | 745.95 | 1.701M |
| Apr 17, 2024 | 759.20 | 771.83 | 744.88 | 750.77 | 3.069M |
| Apr 16, 2024 | 751.68 | 753.14 | 743.00 | 746.74 | 2.570M |
| Apr 15, 2024 | 760.07 | 768.00 | 749.52 | 750.77 | 2.359M |
| Apr 12, 2024 | 759.57 | 763.50 | 749.78 | 751.64 | 2.495M |
| Apr 11, 2024 | 759.78 | 763.33 | 750.67 | 759.59 | 1.595M |
| Apr 10, 2024 | 751.28 | 765.26 | 746.83 | 761.98 | 1.700M |
| Apr 09, 2024 | 777.64 | 777.82 | 750.65 | 757.24 | 2.465M |
| Apr 08, 2024 | 785.02 | 785.20 | 773.35 | 777.29 | 1.664M |
| Apr 05, 2024 | 765.47 | 786.70 | 763.09 | 784.21 | 2.113M |
| Apr 04, 2024 | 781.54 | 787.90 | 767.82 | 768.08 | 2.354M |
| Apr 03, 2024 | 765.69 | 787.25 | 765.41 | 775.99 | 3.045M |
| Apr 02, 2024 | 755.07 | 765.07 | 753.50 | 763.96 | 2.597M |
| Apr 01, 2024 | 776.00 | 777.50 | 753.82 | 760.55 | 2.921M |
| Mar 28, 2024 | 780.32 | 793.67 | 776.44 | 777.96 | 3.209M |
| Mar 27, 2024 | 778.71 | 785.26 | 767.38 | 778.18 | 2.298M |
| Mar 26, 2024 | 774.20 | 778.33 | 769.00 | 774.90 | 2.099M |
| Mar 25, 2024 | 771.10 | 778.49 | 768.15 | 773.14 | 1.807M |
| Mar 22, 2024 | 770.00 | 777.00 | 767.28 | 770.61 | 1.981M |
| Mar 21, 2024 | 774.00 | 780.54 | 758.88 | 770.26 | 3.013M |
| Mar 20, 2024 | 770.11 | 773.16 | 756.64 | 772.86 | 2.038M |
| Mar 19, 2024 | 758.44 | 773.85 | 755.00 | 772.78 | 2.557M |
| Mar 18, 2024 | 762.28 | 769.68 | 758.25 | 762.66 | 2.521M |
| Mar 15, 2024 | 755.38 | 760.89 | 747.71 | 754.17 | 3.730M |
| Mar 14, 2024 | 764.95 | 768.00 | 749.40 | 760.73 | 2.648M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
106.79
Minimum
Jul 19 2019
792.28
Maximum
Mar 04 2024
288.01
Average
245.05
Median
Oct 25 2021
Price Benchmarks
| Amgen Inc | 268.94 |
| Madrigal Pharmaceuticals Inc | 212.09 |
| Vertex Pharmaceuticals Inc | 394.20 |
| Viking Therapeutics Inc | 63.32 |
| Moderna Inc | 101.38 |
Price Related Metrics
| PE Ratio | 127.74 |
| PS Ratio | 19.21 |
| Price to Book Value | 64.11 |
| Earnings Yield | 0.78% |
| Market Cap | 690.59B |
| Operating PE Ratio | 59.49 |
| Normalized PE Ratio | 79.21 |